Grifols Profit Margin 2012-2018 | GRFS

Current and historical gross margin, operating margin and net profit margin for Grifols (GRFS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Grifols net profit margin as of September 30, 2018 is 16.55%.
Grifols Annual Profit Margins
Grifols Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $14.128B $4.878B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.572B 11.48
Zoetis (ZTS) United States $42.477B 29.08
Tilray (TLRY) United States $9.687B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.785B 12.61
Neurocrine Biosciences (NBIX) United States $8.024B 1769.80
Ionis Pharmaceuticals (IONS) United States $7.331B 0.00
Nektar Therapeutics (NKTR) United States $6.598B 9.46
Impax Laboratories (AMRX) United States $5.553B 29.52
Catalent (CTLT) United States $5.466B 22.93
Sage Therapeutics (SAGE) United States $5.035B 0.00
United Therapeutics (UTHR) United States $4.935B 8.07
Loxo Oncology (LOXO) United States $4.516B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.906B 14.46
FibroGen (FGEN) United States $3.346B 0.00
USANA Health Sciences (USNA) United States $2.872B 24.44
Endo (ENDP) Ireland $2.811B 4.31
TESARO (TSRO) United States $2.338B 0.00
Xencor (XNCR) United States $2.113B 0.00
Endocyte (ECYT) United States $1.935B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.888B 255.06
Aerie Pharmaceuticals (AERI) United States $1.866B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.838B 0.00
Heron Therapeutics (HRTX) United States $1.816B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.755B 0.00
Zogenix (ZGNX) United States $1.692B 0.00
PTC Therapeutics (PTCT) United States $1.619B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.552B 18.97
Corcept Therapeutics (CORT) United States $1.415B 20.76
Theravance Biopharma (TBPH) Cayman Islands $1.374B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.360B 0.00
Portola Pharmaceuticals (PTLA) United States $1.281B 0.00
Esperion Therapeutics (ESPR) United States $1.225B 0.00
Tricida (TCDA) United States $1.221B 0.00
TherapeuticsMD (TXMD) United States $1.149B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.083B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.954B 0.00
ImmunoGen (IMGN) United States $0.796B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.730B 0.00
Radius Health (RDUS) United States $0.706B 0.00
Karyopharm Therapeutics (KPTI) United States $0.620B 0.00
Flexion Therapeutics (FLXN) United States $0.596B 0.00
Collegium Pharmaceutical (COLL) United States $0.570B 0.00
GlycoMimetics (GLYC) United States $0.510B 0.00
ChemoCentryx (CCXI) United States $0.482B 38.12
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.452B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.435B 0.00
Dermira (DERM) United States $0.425B 0.00
Dova Pharmaceuticals (DOVA) United States $0.418B 0.00
Xeris Pharmaceuticals (XERS) United States $0.412B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.409B 24.13
Forty Seven (FTSV) United States $0.397B 0.00
Akebia Therapeutics (AKBA) United States $0.396B 0.00
Odonate Therapeutics (ODT) United States $0.395B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.387B 0.00
OptiNose (OPTN) United States $0.386B 0.00
ArQule (ARQL) United States $0.386B 0.00
CASI Pharmaceuticals (CASI) United States $0.379B 0.00
Aclaris Therapeutics (ACRS) United States $0.351B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Zafgen (ZFGN) United States $0.343B 0.00
Depomed (ASRT) United States $0.343B 12.76
KalVista Pharmaceuticals (KALV) United States $0.340B 0.00
Aquestive Therapeutics (AQST) United States $0.329B 0.00
Minerva Neurosciences (NERV) United States $0.327B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.317B 0.00
Translate Bio (TBIO) United States $0.316B 0.00
Aratana Therapeutics (PETX) United States $0.311B 0.00
Mast Therapeutics (SVRA) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.291B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.287B 0.00
Tapimmune (MRKR) United States $0.284B 0.00
Majesco Entertainment (PTE) United States $0.276B 0.00
Affimed (AFMD) Germany $0.267B 0.00
IMV INC (IMV) Canada $0.248B 0.00
Lannett Co Inc (LCI) United States $0.226B 1.97
Aldeyra Therapeutics (ALDX) United States $0.222B 0.00
Tyme Technologies (TYME) United States $0.221B 0.00
Ocular Therapeutix (OCUL) United States $0.210B 0.00
Opexa Therapeutics (ACER) United States $0.210B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.210B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.206B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.199B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.193B 0.00
MEI Pharma (MEIP) United States $0.191B 0.00
Neon Therapeutics (NTGN) United States $0.180B 0.00
Calithera Biosciences (CALA) United States $0.180B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.176B 0.00
Ardelyx (ARDX) United States $0.176B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 0.00
ElectroCore (ECOR) United States $0.169B 0.00
Molecular Templates (MTEM) United States $0.166B 0.00
Redhill Biopharma (RDHL) Israel $0.162B 0.00
ContraFect (CFRX) United States $0.160B 0.00
MediWound (MDWD) Israel $0.155B 0.00
Jounce Therapeutics (JNCE) United States $0.144B 0.00
Melinta Therapeutics (MLNT) United States $0.143B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Recro Pharma (REPH) United States $0.138B 0.00
DURECT (DRRX) United States $0.135B 0.00
Adherex Technologies (FENC) United States $0.133B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.123B 0.00
ProNAi Therapeutics (SRRA) Canada $0.119B 0.00
Cardiome Pharma (CORV) Canada $0.117B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.116B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.108B 0.00
Rafael Holdings (RFL) United States $0.105B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.100B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.096B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.095B 0.00
CTI BioPharma (CTIC) United States $0.090B 0.00
Achaogen (AKAO) United States $0.090B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.084B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.080B 0.00
Iterum Therapeutics (ITRM) Ireland $0.079B 0.00
Infinity Pharmaceuticals (INFI) United States $0.077B 0.00
Otonomy (OTIC) United States $0.073B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Natural Alternatives (NAII) United States $0.070B 6.94
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
KemPharm (KMPH) United States $0.063B 0.00
Immune Design (IMDZ) United States $0.063B 0.00
Forward Pharma (FWP) Denmark $0.063B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.058B 0.00
Avenue Therapeutics (ATXI) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 35.00
Novan (NOVN) United States $0.055B 0.00
Neos Therapeutics (NEOS) United States $0.052B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.048B 0.00
Heat Biologics (HTBX) United States $0.048B 0.00
Capnia (SLNO) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Trillium Therapeutics (TRIL) Canada $0.040B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.038B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.94
Lipocine (LPCN) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
HANCOCK JAFFE (HJLI) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 6.65
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.017B 0.00
Shineco (TYHT) China $0.016B 1.58
Aradigm (ARDM) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Bio-Path Holdings (BPTH) United States $0.007B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
PharmAthene (ALT) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00